Home
Conditions
Glioblastoma Multiforme

Clinical trial condition

Glioblastoma Multiforme

Explore clinical trials studying Glioblastoma Multiforme. Study availability and eligibility vary by location and protocol.

281 public trials 55 recruiting studies

Refine in advanced search Browse all conditions

Glioblastoma Multiforme trial results

Completed

Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients

NCT01135875

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Completed

Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma

NCT00501891

Conditions: Astrocytoma, Central Nervous System Neoplasms, Glioblastoma, +12 more
Locations: Duke University Medical Center (Brain Tumor Center) Durham, North Carolina, United States

View Trial Details

Completed

A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

NCT00704080

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +10 more
Locations: Investigational Site Number Birmingham, Alabama, United States

Investigational Site Number Los Angeles, California, United States

Investigational Site Number Boston, Massachusetts, United States

Investigational Site Number New York, United States

View Trial Details

Completed

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

NCT00409214

Conditions: Anaplastic Astrocytoma, Astrocytoma, Glioblastoma, +9 more
Locations: Institute of Neurosurgery, Clinical Centre Serbia Belgrade, Serbia

View Trial Details

Completed

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

NCT01294735

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +16 more
Locations: Not specified

View Trial Details

Completed

Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients

NCT01089868

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Department of Stereotactic Neurosurgery Freiburg im Breisgau, Baden-Wurttemberg, Germany

University Hospital Munich, Department of Neurosurgery Munich, Bavaria, Germany

University Hospital Bonn, Department of Neurosurgery Bonn, North Rhine-Westphalia, Germany

View Trial Details

Completed

Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme

NCT01285414

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations: Stanford University Stanford, California, United States

University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Completed

Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas

NCT00412542

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

NCT00504660

Conditions: Anaplastic Glioma of Brain, Astrocytoma, Brain Cancer, +17 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)

NCT00817284

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Århus Hospital Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

Odense Hospital Odense, Denmark

View Trial Details

Glioblastoma Multiforme

Glioblastoma Multiforme trial results

Related conditions